Our Clinical Product History

In 50 years, technology and innovation has pushed forward the field of in vitro diagnostics. Just look at the images and see how far we have come in just a short time! bioMérieux is proud to have played a part in helping you provide ever more relevant and faster results to improve patient management and healthcare. Our partnership approach with customers enables us to see where you need help most and that’s where we work hard to find new products, services or solutions.

		1967 The Fibrometer is added to the BD Mérieux catalog, and is quickly adopted by a quarter (approx. 1,000) of Frace’s laboratories
		1969 The first toxoplasmosis detection kit (diagnosis of toxoplasmosis by immunofluorescence) Launch of miniaturized API^® strip by API^®System*
		1972 Production and sale of the first ready-to-use culture media in Petri plates
		1974 Launch of the SLIDEX^® Meningitis kit (first test enabling the diagnosis of an infectious disease without prior culture, with results in 5 minutes compared to several days previously)
		1979 First ATB^TM Antibiotic Susceptibility test strip by API^®System*
		1985 First HIV screening test: VIRONOSTIKA^® HIV anti-HTLV-III by Organon Teknika*
		1989 Development of chromogenic media (culture media that enables identification of microbial colonies by coloring them). Today the range is called CHROMID^®.
		1990 Acquisition of the BOOM extraction and NASBA amplification technologies for molecular diagnostics
		1991 Launch of the VIDAS^® with 8 initial kits (today VIDAS^® has close to 100 parameters)
		1992 VIDAS^® automated immunoassay platform adapted for industrial applications
		1995 VIDAS^® D-Dimer Exclusion^TM is the first test used to rule out the diagnosis of deep vein thrombosis and pulmonary embolism to be certified by the FDA
		1997 Launch of: BacT/ALERT^® 3D, an advanced automated system for the detection of microbial agents from Organon Teknika* VITEK^® 2, automated bacterial identification and antibiotic susceptibility testing system
		2002 NUCLISENS^® EASYQ^® (molecular diagnostics platform for amplification and real-time detection) NUCLISENS^® EASYQ^® HIV-1: the first real-time test for measuring HIV-1 viral load
		2004 Launch of VITEK^® 2 Compact
		2009 Launch of PREVI^® Isola for the automated inoculation of culture media, and PREVI^® Color Gram for automated Gram staining
		2010 BACT/ALERT^® 3D Dual-T, a microbial detection system used for sterility testing in the biopharmaceutical industry Launch of Myla^® middleware
		2011 Inauguration of the laboratory of the future, at Marcy l’Étoile, France (over 1,000 visits from biologists and scientists in a year). Development of a similar unit in Saint Louis, Missouri (USA). The laboratories enable discussions to align bioMérieux’s future products and services with customer needs Launch of CE-marked VITEK^® MS, used in association with the VITEK^®2 system for antibiotic susceptibility testing First bioNexia^® rapid tests commercialized by bioMérieux
		2012 Launch of VITEK®MS, a bacterial identification system using MALDI-TOF mass spectrometry, for industrial applications Presentation of VIDAS® 3, the new generation of the VIDAS^® immunoassay platform
		2013 FDA approval of novel molecular test, THxID™-BRAF, a companion test for late stage metastatic melanoma tumor samples HxIDTM-BRAFTHxID^™-BRAF, a companion diagnostic test for late stage metastatic melinoma tumor samplesmarkers D VITEK®MS, a bacterial identification system using MALDI-TOF mass spectrometry, for industrial applications